TCL Archive Republican Congress To Shift Priorities, But Cancer May Get New Opportunities November 18, 1994
TCL Archive Treatment Progress Since 1972 Provides Powerful Support For Continuing National Cancer Program March 23, 1979
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
